Cargando…
What are the obligations of pharmaceutical companies in a global health emergency?
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342311/ https://www.ncbi.nlm.nih.gov/pubmed/34364412 http://dx.doi.org/10.1016/S0140-6736(21)01378-7 |
_version_ | 1783734039532797952 |
---|---|
author | Emanuel, Ezekiel J Buchanan, Allen Chan, Shuk Ying Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R J McCoy, Matthew S Norheim, Ole F Saenz, Carla Schaefer, G Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Persad, Govind |
author_facet | Emanuel, Ezekiel J Buchanan, Allen Chan, Shuk Ying Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R J McCoy, Matthew S Norheim, Ole F Saenz, Carla Schaefer, G Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Persad, Govind |
author_sort | Emanuel, Ezekiel J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8342311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83423112021-08-06 What are the obligations of pharmaceutical companies in a global health emergency? Emanuel, Ezekiel J Buchanan, Allen Chan, Shuk Ying Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R J McCoy, Matthew S Norheim, Ole F Saenz, Carla Schaefer, G Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Persad, Govind Lancet Viewpoint Elsevier Ltd. 2021 2021-08-06 /pmc/articles/PMC8342311/ /pubmed/34364412 http://dx.doi.org/10.1016/S0140-6736(21)01378-7 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Viewpoint Emanuel, Ezekiel J Buchanan, Allen Chan, Shuk Ying Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R J McCoy, Matthew S Norheim, Ole F Saenz, Carla Schaefer, G Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Persad, Govind What are the obligations of pharmaceutical companies in a global health emergency? |
title | What are the obligations of pharmaceutical companies in a global health emergency? |
title_full | What are the obligations of pharmaceutical companies in a global health emergency? |
title_fullStr | What are the obligations of pharmaceutical companies in a global health emergency? |
title_full_unstemmed | What are the obligations of pharmaceutical companies in a global health emergency? |
title_short | What are the obligations of pharmaceutical companies in a global health emergency? |
title_sort | what are the obligations of pharmaceutical companies in a global health emergency? |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342311/ https://www.ncbi.nlm.nih.gov/pubmed/34364412 http://dx.doi.org/10.1016/S0140-6736(21)01378-7 |
work_keys_str_mv | AT emanuelezekielj whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT buchananallen whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT chanshukying whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT fabrececile whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT hallidaydaniel whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT heathjoseph whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT herzoglisa whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT lelandrj whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT mccoymatthews whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT norheimolef whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT saenzcarla whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT schaefergowen whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT tankokchor whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT wellmanchristopherheath whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT wolffjonathan whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency AT persadgovind whataretheobligationsofpharmaceuticalcompaniesinaglobalhealthemergency |